David J. Straus

1.6k total citations
23 papers, 1.2k citations indexed

About

David J. Straus is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, David J. Straus has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 8 papers in Genetics. Recurrent topics in David J. Straus's work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (7 papers). David J. Straus is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (7 papers). David J. Straus collaborates with scholars based in United States and Israel. David J. Straus's co-authors include Lawrence D. Kaplan, Marcia A. Testa, Yuliya Jhanwar, Andrew J. Vickers, Barrie R. Cassileth, Raymond P. Warrell, Charles W. Young, Craig J. Coonley, Donald W. Northfelt and Jenny Huang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

David J. Straus

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Straus United States 15 634 498 187 173 167 23 1.2k
Hideko Nakahara Japan 10 277 0.4× 116 0.2× 81 0.4× 97 0.6× 66 0.4× 20 1.2k
Chiara Crotti Italy 17 159 0.3× 113 0.2× 148 0.8× 70 0.4× 76 0.5× 56 1.1k
Robert L. Phyliky United States 21 225 0.4× 598 1.2× 573 3.1× 61 0.4× 23 0.1× 48 1.4k
Susan Wright Australia 17 160 0.3× 129 0.3× 309 1.7× 45 0.3× 28 0.2× 52 1.3k
David Andorsky United States 15 555 0.9× 397 0.8× 226 1.2× 68 0.4× 34 0.2× 71 1.2k
Virginia Dalton United States 10 443 0.7× 180 0.4× 74 0.4× 77 0.4× 194 1.2× 17 1.7k
Naoe Goto Japan 22 397 0.6× 470 0.9× 121 0.6× 128 0.7× 30 0.2× 66 1.2k
Ronald Rosenburg Germany 8 83 0.1× 178 0.4× 203 1.1× 45 0.3× 77 0.5× 11 1.2k
Maher Issa United States 19 168 0.3× 151 0.3× 130 0.7× 59 0.3× 25 0.1× 26 965
J. Sydney Stillman United States 14 229 0.4× 169 0.3× 97 0.5× 40 0.2× 101 0.6× 23 1.4k

Countries citing papers authored by David J. Straus

Since Specialization
Citations

This map shows the geographic impact of David J. Straus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Straus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Straus more than expected).

Fields of papers citing papers by David J. Straus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Straus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Straus. The network helps show where David J. Straus may publish in the future.

Co-authorship network of co-authors of David J. Straus

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Straus. A scholar is included among the top collaborators of David J. Straus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Straus. David J. Straus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buege, Michael J., et al.. (2020). IVAC +/- R for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era. Blood. 136(Supplement 1). 10–10.
2.
Ni, Ai, et al.. (2019). Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody. Leukemia & lymphoma. 61(2). 364–369. 11 indexed citations
3.
Cooper, Richard A. & David J. Straus. (2012). Clinical Guidelines, the Politics of Value, and the Practice of Medicine: Physicians at the Crossroads. Journal of Oncology Practice. 8(4). 233–235. 4 indexed citations
4.
Balagula, Yevgeniy, David J. Straus, Melissa Pulitzer, & Mario E. Lacouture. (2011). Necrobiotic Xanthogranuloma Associated With Immunoglobulin M Paraproteinemia in a Patient With Waldenström Macroglobulinemia. Journal of Clinical Oncology. 29(11). e305–e307. 11 indexed citations
5.
Straus, David J.. (2001). HIV-Associated lymphomas. Current Oncology Reports. 3(3). 260–265. 13 indexed citations
6.
Shavelle, Robert M., David J. Straus, & Steven M. Day. (2001). ‘Comparison of survival in cerebral palsy between countries.’. Developmental Medicine & Child Neurology. 43(8). 574–574. 5 indexed citations
7.
Vander, Nicholas, et al.. (2000). Abnormal Flow Volume Loops in Patients With Intrathoracic Hodgkin's Disease. CHEST Journal. 117(5). 1256–1261. 20 indexed citations
8.
9.
Straus, David J.. (1997). HIV-associated lymphomas. Current Opinion in Oncology. 9(5). 450–454. 22 indexed citations
10.
Kaplan, Lawrence D., David J. Straus, Marcia A. Testa, et al.. (1997). Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 336(23). 1641–1648. 254 indexed citations
11.
Straus, David J.. (1996). 7c Treatment of Hodgkin's disease: the role of radio-and/or chemotherapy in advanced stages. Baillière s Clinical Haematology. 9(3). 553–558. 3 indexed citations
12.
Straus, David J., George Y. Wong, John Liu, et al.. (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American Journal of Medicine. 90(3). 328–337. 41 indexed citations
13.
Straus, David J., George Y. Wong, John Liu, et al.. (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, burkitt's type) in american adults: Results with treatment designed for acute lymphoblastic leukemia. The American Journal of Medicine. 90(1). 328–337. 15 indexed citations
14.
Scheinberg, David A., David J. Straus, Chaitanya Divgi, et al.. (1990). A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.. Journal of Clinical Oncology. 8(5). 792–803. 74 indexed citations
15.
Lowenthal, Dennis A., et al.. (1987). Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man. Cancer. 60(10). 2454–2458. 45 indexed citations
16.
Straus, David J., et al.. (1987). Non-hodgkin's lymphomas: Characteristics of long-term survivors following conservative treatment. The American Journal of Medicine. 82(2). 247–256. 18 indexed citations
17.
Rossleigh, Monica A., et al.. (1986). Osteonecrosis in patients with malignant lymphoma. A review of 31 cases. Cancer. 58(5). 1112–1116. 25 indexed citations
18.
Warrell, Raymond P., Craig J. Coonley, David J. Straus, & Charles W. Young. (1983). Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. Cancer. 51(11). 1982–1987. 100 indexed citations
19.
Schauer, Peter, Z Arlin, Roland Mertelsmann, et al.. (1983). Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.. Journal of Clinical Oncology. 1(8). 462–470. 124 indexed citations
20.
Schulof, Richard S., Burton J. Lee, Mortimer J. Lacher, et al.. (1980). Concanavalin A-induced suppressor cell activity in Hodgkin's disease. Clinical Immunology and Immunopathology. 16(4). 454–462. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideko Nakahara Breakdown of academic impact, for papers by Chiara Crotti Breakdown of academic impact, for papers by Robert L. Phyliky Breakdown of academic impact, for papers by Susan Wright Breakdown of academic impact, for papers by David Andorsky Breakdown of academic impact, for papers by Virginia Dalton Breakdown of academic impact, for papers by Naoe Goto Breakdown of academic impact, for papers by Ronald Rosenburg Breakdown of academic impact, for papers by Maher Issa Breakdown of academic impact, for papers by J. Sydney Stillman
Rankless by CCL
2026